ZymoGenetics, Inc. · Seattle, WA United States
| 1201 Eastlake Ave. East | Phone: 206-442-6600 |
| Seattle, WA | Fax: 206-442-6608 |
| 98102 | |
| United States | 
Map This Company |
ZymoGenetics, Inc. Rankings
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
ZymoGenetics has proteins on its plate. The firm culls genomics databases to indentify and develop protein-based drugs targeting a variety conditions. Its sole commercial product, RECOTHROM (rThrombin), controls bleeding during surgery. Unlike existing forms of thrombin, RECOTHROM is derived from recombinant proteins instead of animal or human blood, which can trigger adverse reactions. The lead candidate in ZymoGenetics' research and development pipeline is an antiviral therapy to treat hepatitis C. The company is a wholly owned subsidiary of
ZymoGenetics, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | SubsidiarySingle Location |
|---|---|
| Fiscal Year-End | December |
| 2009 Employees | 323 |
Executives
15 executives listed for ZymoGenetics, Inc.'s Seattle, WA location.
| Director Scientific Computing; Executive Director | Scott Presnell | |
|---|---|---|
| President and Director | Jeremy Levin | |
| VP | P. Joseph Campisi |